Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2024-05-21 Sale |
2024-05-23 5:15 pm |
Emergent BioSolutions Inc. | EBS | Zoon Kathryn C Director |
1,089 | $5.78 | $6,294 | 48,882 (Direct) |
View |
2024-02-21 Sale |
2024-02-27 8:26 pm |
Emergent BioSolutions Inc. | EBS | LINDAHL RICHARD S EVP, Chief Financial Officer |
4,012 | $2.71 | $10,873 | 168,463 (Direct) |
View |
2023-05-25 Sale |
2023-07-24 08:28 am |
Emergent BioSolutions Inc. | EBS | Zoon Kathryn C Director |
3,530 | $8.3644 | $29,527 | 49,971 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2024-05-23 Option Award |
2024-05-28 9:40 pm |
N/A 2031-05-22 |
Emergent BioSolutions Inc. | EBS | Dayal Sujata Tyagi Director |
43,178 | $0 | 88,877 (Direct) |
View |
2024-05-23 Option Award |
2024-05-28 9:14 pm |
N/A 2031-05-22 |
Emergent BioSolutions Inc. | EBS | SULLIVAN LOUIS W Director |
43,178 | $0 | 130,443 (Direct) |
View |
2024-05-23 Option Award |
2024-05-28 9:14 pm |
N/A 2031-05-22 |
Emergent BioSolutions Inc. | EBS | Harsanyi Zsolt Chairman |
43,178 | $0 | 115,077 (Direct) |
View |
2024-05-23 Option Award |
2024-05-28 9:14 pm |
N/A 2031-05-22 |
Emergent BioSolutions Inc. | EBS | Zoon Kathryn C Director |
43,178 | $0 | 92,060 (Direct) |
View |
2024-05-23 Option Award |
2024-05-28 9:14 pm |
N/A 2031-05-22 |
Emergent BioSolutions Inc. | EBS | Richard Ronald Director |
43,178 | $0 | 96,862 (Direct) |
View |
2024-04-07 Tax Withholding |
2024-04-09 7:27 pm |
N/A N/A |
Emergent BioSolutions Inc. | EBS | Glessner Coleen EVP, Quality & Ethics, and CPL |
585 | $2.29 | 164,383 (Direct) |
View |
2024-04-07 Tax Withholding |
2024-04-09 7:27 pm |
N/A N/A |
Emergent BioSolutions Inc. | EBS | Hartzel William SVP, Bioservices |
665 | $2.29 | 34,274 (Direct) |
View |
2024-03-13 Option Award |
2024-03-15 5:16 pm |
N/A 2031-03-12 |
Emergent BioSolutions Inc. | EBS | PAPA JOSEPH C President and CEO |
750,000 | $0 | 750,000 (Direct) |
View |
2024-03-13 Option Award |
2024-03-15 5:16 pm |
N/A 2031-03-12 |
Emergent BioSolutions Inc. | EBS | Williams Paul Anthony SVP, Products Business |
125,000 | $0 | 147,614 (Direct) |
View |
2024-03-13 Option Award |
2024-03-15 5:16 pm |
N/A 2031-03-12 |
Emergent BioSolutions Inc. | EBS | Glessner Coleen EVP, Quality & Ethics, and CPL |
125,000 | $0 | 187,113 (Direct) |
View |
2024-03-13 Option Award |
2024-03-15 5:16 pm |
N/A 2031-03-12 |
Emergent BioSolutions Inc. | EBS | Fox Jennifer Lynne EVP, Ext Aff, GC, Corp Sec |
125,000 | $0 | 223,169 (Direct) |
View |
2024-03-13 Option Award |
2024-03-15 5:15 pm |
N/A 2031-03-12 |
Emergent BioSolutions Inc. | EBS | LINDAHL RICHARD S EVP, Chief Financial Officer |
125,000 | $0 | 305,944 (Direct) |
View |
2024-03-13 Option Award |
2024-03-15 5:15 pm |
N/A 2031-03-12 |
Emergent BioSolutions Inc. | EBS | Hartzel William SVP, Bioservices |
125,000 | $0 | 152,211 (Direct) |
View |
2024-03-05 Tax Withholding |
2024-03-07 8:31 pm |
N/A N/A |
Emergent BioSolutions Inc. | EBS | Hartzel William SVP, Bioservices |
346 | $3.41 | 34,939 (Direct) |
View |
2024-03-01 Tax Withholding |
2024-03-04 6:43 pm |
N/A N/A |
Emergent BioSolutions Inc. | EBS | Glessner Coleen EVP, Quality & Ethics, and CPL |
381 | $3.39 | 164,968 (Direct) |
View |
2024-02-29 Tax Withholding |
2024-03-04 6:43 pm |
N/A N/A |
Emergent BioSolutions Inc. | EBS | Williams Paul Anthony SVP, Products Business |
450 | $3.23 | 24,882 (Direct) |
View |
2024-03-01 Tax Withholding |
2024-03-04 6:43 pm |
N/A N/A |
Emergent BioSolutions Inc. | EBS | Williams Paul Anthony SVP, Products Business |
137 | $3.39 | 24,882 (Direct) |
View |
2024-02-29 Tax Withholding |
2024-03-04 6:42 pm |
N/A N/A |
Emergent BioSolutions Inc. | EBS | LINDAHL RICHARD S EVP, Chief Financial Officer |
9,037 | $3.23 | 158,742 (Direct) |
View |
2024-03-01 Tax Withholding |
2024-03-04 6:42 pm |
N/A N/A |
Emergent BioSolutions Inc. | EBS | LINDAHL RICHARD S EVP, Chief Financial Officer |
684 | $3.39 | 158,742 (Direct) |
View |
2024-02-29 Tax Withholding |
2024-03-04 6:42 pm |
N/A N/A |
Emergent BioSolutions Inc. | EBS | Fox Jennifer Lynne EVP, Ext Aff, GC, Corp Sec |
4,103 | $3.23 | 173,758 (Direct) |
View |
2024-03-01 Tax Withholding |
2024-03-04 6:42 pm |
N/A N/A |
Emergent BioSolutions Inc. | EBS | Fox Jennifer Lynne EVP, Ext Aff, GC, Corp Sec |
703 | $3.39 | 173,758 (Direct) |
View |
Ownership |
2024-02-29 10:02 am |
N/A N/A |
Emergent BioSolutions Inc. | EBS | PAPA JOSEPH C President and CEO |
0 | $0 | 0 (Direct) |
View |
2024-02-23 Tax Withholding |
2024-02-27 8:30 pm |
N/A N/A |
Emergent BioSolutions Inc. | EBS | Williams Paul Anthony SVP, Products Business |
105 | $2.74 | 25,469 (Direct) |
View |
2024-02-23 Tax Withholding |
2024-02-27 8:28 pm |
N/A N/A |
Emergent BioSolutions Inc. | EBS | Fox Jennifer Lynne EVP, Ext Aff, GC, Corp Sec |
229 | $2.74 | 178,564 (Direct) |
View |
2024-02-23 Tax Withholding |
2024-02-27 8:26 pm |
N/A N/A |
Emergent BioSolutions Inc. | EBS | LINDAHL RICHARD S EVP, Chief Financial Officer |
517 | $2.74 | 168,463 (Direct) |
View |
2023-11-11 Tax Withholding |
2023-11-14 7:28 pm |
N/A N/A |
Emergent BioSolutions Inc. | EBS | Fox Jennifer Lynne EVP, Ext Aff, GC, Corp Sec |
413 | $2 | 178,793 (Direct) |
View |
2023-11-13 Tax Withholding |
2023-11-14 7:27 pm |
N/A N/A |
Emergent BioSolutions Inc. | EBS | Williams Paul Anthony SVP, Products Business |
566 | $1.82 | 25,574 (Direct) |
View |
2023-11-11 Tax Withholding |
2023-11-14 7:26 pm |
N/A N/A |
Emergent BioSolutions Inc. | EBS | Hartzel William SVP, Bioservices |
632 | $2 | 35,285 (Direct) |
View |
2023-10-03 Option Award |
2023-10-05 7:10 pm |
N/A N/A |
Emergent BioSolutions Inc. | EBS | Fowler Neal Franklin Director |
118,670 | $0 | 118,670 (Direct) |
View |
2023-10-03 Option Award |
2023-10-05 7:08 pm |
N/A N/A |
Emergent BioSolutions Inc. | EBS | DeGolyer Donald W Director |
118,670 | $0 | 118,670 (Direct) |
View |
Ownership |
2023-10-05 7:05 pm |
N/A N/A |
Emergent BioSolutions Inc. | EBS | Fowler Neal Franklin Director |
0 | $0 | 0 (Direct) |
View |
Ownership |
2023-10-05 7:01 pm |
N/A N/A |
Emergent BioSolutions Inc. | EBS | DeGolyer Donald W Director |
0 | $0 | 0 (Direct) |
View |
Ownership |
2023-08-15 12:36 pm |
N/A N/A |
Emergent BioSolutions Inc. | EBS | Hartzel William SVP, Bioservices |
0 | $0 | 63,128 (Direct) |
View |
2023-07-08 Tax Withholding |
2023-07-24 08:29 am |
N/A N/A |
Emergent BioSolutions Inc. | EBS | Williams Paul Anthony SVP, Products Business |
85 | $0 | 26,140 (Direct) |
View |
Ownership |
2023-07-18 6:22 pm |
N/A N/A |
Emergent BioSolutions Inc. | EBS | MILLER H HAYWOOD III Interim CEO |
0 | $0 | 0 (Direct) |
View |
2023-06-09 Option Award |
2023-06-13 9:23 pm |
N/A 2030-06-08 |
Emergent BioSolutions Inc. | EBS | Williams Paul Anthony SVP, Products Business |
13,847 | $0 | 48,839 (Direct) |
View |
2023-06-09 Option Award |
2023-06-13 9:22 pm |
N/A 2030-06-08 |
Emergent BioSolutions Inc. | EBS | Glessner Coleen EVP, Quality & Ethics, and CPL |
46,155 | $0 | 227,462 (Direct) |
View |
2023-06-09 Option Award |
2023-06-13 9:22 pm |
N/A 2030-06-08 |
Emergent BioSolutions Inc. | EBS | Fox Jennifer Lynne EVP, Ext Aff, GC, Corp Sec |
73,847 | $0 | 277,375 (Direct) |
View |
2023-06-09 Option Award |
2023-06-13 9:21 pm |
N/A 2030-06-08 |
Emergent BioSolutions Inc. | EBS | LINDAHL RICHARD S EVP, Chief Financial Officer |
73,847 | $0 | 353,936 (Direct) |
View |
2023-06-09 Option Award |
2023-06-13 9:20 pm |
N/A 2030-06-08 |
Emergent BioSolutions Inc. | EBS | Havey Adam EVP, Business Operations |
73,847 | $0 | 336,304 (Direct) |
View |
2023-06-09 Option Award |
2023-06-13 9:20 pm |
N/A 2030-06-08 |
Emergent BioSolutions Inc. | EBS | Kramer Robert President and CEO |
212,308 | $0 | 1,041,110 (Direct) |
View |